The significant differential gene enrichment in CD4+ T cells in pathways such as asthma and inflammatory bowel disease is consistent with some clinical symptoms of DOCK8‐deficient patients, suggesting that the DOCK8 mutation is related to these diseases. This evidence concerns the gene CD4 and inflammatory bowel disease.